BIOMAT Database Logo BIOMAT Database Logo

Primary lung adenocarcinoma with massive lymphocyte infiltration. 2005

Koji Tsuta, and Genichiro Ishii, and Eigaku Kim, and Satoshi Shiono, and Yutaka Nishiwaki, and Yasushi Endoh, and Tetsuro Kodama, and Kanji Nagai, and Kanji Nagai
Pathology Division, National Cancer Center Research, Institute East and the Clinical Laboratory, National Cancer Center Hospital East, Chiba, Japan.

We report 6 cases of adenocarcinoma with massive lymphocyte infiltration. This adenocarcinoma is found in 0.7% of surgically resected primary lung adenocarcinomas. The tumor was located in the peripheral portion in all cases. Lymph node metastasis was detected in 4 cases. The mean follow-up period was 49.8 months; all patients were alive without recurrence despite advanced pathologic stage. Histologically, the tumors revealed an acinar and glandular structure, and the cancer epithelium was destroyed by infiltrating lymphocytes. The lung parenchyma was destroyed by the severe inflammatory cell infiltration without dense fibrosis. Immunohistochemical staining revealed that most infiltrating lymphocytes were positive for CD3 or CD20. None of the tumors were positive for latent membrane protein-1, bcl-2, or Epstein-Barr virus-encoded small RNA-1. This type of adenocarcinoma occurs in old age, and good outcome and distinctive histologic features were observed. We refer to it as primary lung adenocarcinoma with massive lymphocyte infiltration.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Koji Tsuta, and Genichiro Ishii, and Eigaku Kim, and Satoshi Shiono, and Yutaka Nishiwaki, and Yasushi Endoh, and Tetsuro Kodama, and Kanji Nagai, and Kanji Nagai
Cytological features of lung adenocarcinoma with massive lymphocyte infiltration.
April 2012, Journal of cytology,
Koji Tsuta, and Genichiro Ishii, and Eigaku Kim, and Satoshi Shiono, and Yutaka Nishiwaki, and Yasushi Endoh, and Tetsuro Kodama, and Kanji Nagai, and Kanji Nagai
Pulmonary adenocarcinoma with massive lymphocyte infiltration: report of three cases.
October 2003, Lung cancer (Amsterdam, Netherlands),
Koji Tsuta, and Genichiro Ishii, and Eigaku Kim, and Satoshi Shiono, and Yutaka Nishiwaki, and Yasushi Endoh, and Tetsuro Kodama, and Kanji Nagai, and Kanji Nagai
RASAL3 predicts overall survival and CD8+ T lymphocyte infiltration in lung adenocarcinoma.
December 2022, Journal of cellular and molecular medicine,
Koji Tsuta, and Genichiro Ishii, and Eigaku Kim, and Satoshi Shiono, and Yutaka Nishiwaki, and Yasushi Endoh, and Tetsuro Kodama, and Kanji Nagai, and Kanji Nagai
T Lymphocyte Infiltration in Association with IDO1 Expression in Resected Lung Adenocarcinoma and Normal Adjacent Lung Tissues.
January 2022, BioMed research international,
Koji Tsuta, and Genichiro Ishii, and Eigaku Kim, and Satoshi Shiono, and Yutaka Nishiwaki, and Yasushi Endoh, and Tetsuro Kodama, and Kanji Nagai, and Kanji Nagai
Moesin as a prognostic indicator of lung adenocarcinoma improves prognosis by enhancing immune lymphocyte infiltration.
April 2021, World journal of surgical oncology,
Koji Tsuta, and Genichiro Ishii, and Eigaku Kim, and Satoshi Shiono, and Yutaka Nishiwaki, and Yasushi Endoh, and Tetsuro Kodama, and Kanji Nagai, and Kanji Nagai
Primary lung adenocarcinoma with enteric morphology associated with primary colon adenocarcinoma.
April 2016, Archivos de bronconeumologia,
Koji Tsuta, and Genichiro Ishii, and Eigaku Kim, and Satoshi Shiono, and Yutaka Nishiwaki, and Yasushi Endoh, and Tetsuro Kodama, and Kanji Nagai, and Kanji Nagai
Adenocarcinoma of the lung presenting with massive subcutaneous emphysema.
July 2015, BMJ case reports,
Koji Tsuta, and Genichiro Ishii, and Eigaku Kim, and Satoshi Shiono, and Yutaka Nishiwaki, and Yasushi Endoh, and Tetsuro Kodama, and Kanji Nagai, and Kanji Nagai
PD-L1 expression is associated with massive lymphocyte infiltration and histology in gastric cancer.
September 2016, Human pathology,
Koji Tsuta, and Genichiro Ishii, and Eigaku Kim, and Satoshi Shiono, and Yutaka Nishiwaki, and Yasushi Endoh, and Tetsuro Kodama, and Kanji Nagai, and Kanji Nagai
Prolonged survival of a patient affected by pancreatic adenocarcinoma with massive lymphocyte and dendritic cell infiltration after interleukin-2 immunotherapy. Report of a case.
January 2008, Tumori,
Koji Tsuta, and Genichiro Ishii, and Eigaku Kim, and Satoshi Shiono, and Yutaka Nishiwaki, and Yasushi Endoh, and Tetsuro Kodama, and Kanji Nagai, and Kanji Nagai
Patient with lung adenocarcinoma manifesting as an unusual migratory pulmonary infiltration.
July 2015, BMJ case reports,
Copied contents to your clipboard!